Company · CIK 1858848
Tenaya Therapeutics, Inc.
| CIK | 1858848 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | TNYA (Nasdaq) |
| First annual or quarterly report | 2021-09-08 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286005 | 2025-03-21 | 2025-12-12 | 4 | |
| 333-266741 | 2022-08-10 | 2025-03-04 | 8 | |
| 333-257820 | 2021-07-09 | 2021-07-30 | 4 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-12-12 | 424B5Shelf takedown | 333-286005 | 0001193125-25-317609 |
| 2025-12-11 | 424B5Shelf takedown | 333-286005 | 0001193125-25-316104 |
| 2025-03-31 | EFFECTDeclared effective | 333-286005 | 9999999995-25-000905 |
| 2025-03-21 | S-3Shelf registered | 333-286005 | 0001193125-25-060227 |
| 2025-03-04 | 424B5Shelf takedown | 333-266741 | 0001193125-25-045610 |
| 2025-03-03 | 424B5Shelf takedown | 333-266741 | 0001193125-25-044134 |
| 2024-02-08 | 424B5Shelf takedown | 333-266741 | 0001193125-24-028514 |
| 2022-11-17 | 424B5Shelf takedown | 333-266741 | 0001193125-22-287677 |
| 2022-11-16 | 424B5Shelf takedown | 333-266741 | 0001193125-22-286840 |
| 2022-08-17 | EFFECTDeclared effective | 333-266741 | 9999999995-22-002422 |
| 2022-08-17 | 424B5Shelf takedown | 333-266741 | 0001193125-22-223273 |
| 2022-08-10 | S-3Shelf registered | 333-266741 | 0001193125-22-217445 |
| 2021-07-30 | 424B4Final prospectus | 333-257820 | 0001193125-21-231612 |
| 2021-07-29 | EFFECTDeclared effective | 333-257820 | 9999999995-21-002984 |
| 2021-07-26 | S-1/AAmendment | 333-257820 | 0001193125-21-223559 |
| 2021-07-09 | S-1Registration filed | 333-257820 | 0001193125-21-212010 |
| 2021-05-07 | DRSDraft made public | 377-04815 | 0000950123-21-005602 |